Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 11 (6) , 559-567
- https://doi.org/10.1097/00008390-200112000-00002
Abstract
Nitric oxide (NO) is known to facilitate tumour metastasis through the promotion of angiogenesis, vascular dilation, platelet aggregation, etc. In the present study we explored its novel role in producing dysfunction of the host immune system in the metastasis of murine metastatic melanoma B16-BL6 cells. A significant reduction in the mixed lymphocyte reaction (MLR) was observed in the spleen cells from B16-BL6-bearing mice, but not in those from mice bearing the parent cell B16. When B16-BL6 cells were added in vitro to the MLR, a significant decrease was also found, even when they were co-cultured with the lymphocytes in two compartments of a Transwell chamber separated by an 8.0 μm filter. The supernatant from cultured B16-BL6 but not B16 cells, which had a greatly increased NO activity, significantly inhibited concanavalin A- and lipopolysaccharide-induced lymphocyte proliferation. A remarkably higher expression of inducible NO synthase (iNOS) was detected in B16-BL6 cells than in B16 cells. Nω-Nitro-l-arginine (l-NNA), a NO synthase inhibitor and superoxide dismutase, significantly antagonized the above inhibition by B16-BL6 cells, while l-arginine, a NO precursor, and S-nitroso-N-acetyl-d,l-penicillamine, a NO donor, strengthened the inhibition. Furthermore, l-NNA significantly inhibited lung metastasis of B16-BL6 cells, while l-arginine tended to enhance the metastasis. The cytotoxicity of B16-BL6-specific T-cells was significantly decreased by pre-culture with B16-BL6 cells in a Transwell chamber or the culture supernatants of B16-BL6 cells, whereas l-iminoethyl-lysine, a selective inhibitor of iNOS, showed a significant recovery from the disease. These results suggest that NO released by metastatic tumour cells may impair the immune system, which facilitates the escape from immunosurveillance and metastasis of tumour cells.Keywords
This publication has 18 references indexed in Scilit:
- Subcellular localization of neuronal nitric oxide synthase in rat small intestineBiochemical Pharmacology, 2000
- Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesisInternational Journal of Cancer, 2000
- Increased in situ expression of nitric oxide synthase in human colorectal cancer.Virchows Archiv, 2000
- Up‐regulation of inducible nitric oxide synthase and production of nitric oxide by the swarm rat and human chondrosarcomaJournal of Orthopaedic Research, 1998
- Extracellular Matrix-Associated Transforming Growth Factor-β: Role in Cancer Cell Growth and InvasionPublished by Elsevier ,1998
- Effects of nitric oxide on the adhesion of human melanocytes to extracellular matrix componentsThe Journal of Pathology, 1997
- Relationship of transforming growth factor beta 1 to angiogenesis in gastric carcinomaJournal of Korean Medical Science, 1997
- Increasedl-arginine transport in a nitric oxide-producing metastatic colon cancer cell lineAnnals of Surgical Oncology, 1996
- Physiological and pathological roles of parathyroid hormone-related peptideCurrent Opinion in Nephrology and Hypertension, 1996
- Nitric oxide synthase activity is up-regulated in melanoma cell linesMelanoma Research, 1996